Evaluation of Dry Sensors for Neonatal EEG Recordings.

PURPOSE: Neonatal seizures are a common neurologic diagnosis in neonatal intensive care units, occurring in approximately 14,000 newborns annually in the United States. Although the only reliable means of detecting and treating neonatal seizures is with an electroencephalography (EEG) recording, many neonates do not receive an EEG or experience delays in getting them. Barriers to obtaining neonatal EEGs include (1) lack of skilled EEG technologists to apply conventional wet electrodes to delicate neonatal skin, (2) poor signal quality because of improper skin preparation and artifact, and (3) extensive time needed to apply electrodes. Dry sensors have the potential to overcome these obstacles but have not previously been evaluated on neonates. METHODS: Sequential and simultaneous recordings with wet and dry sensors were performed for 1 hour on 27 neonates from 35 to 42.5 weeks postmenstrual age. Recordings were analyzed for correlation and amplitude and were reviewed by neurophysiologists. Performance of dry sensors on simulated vernix was examined. RESULTS: Analysis of dry and wet signals showed good time-domain correlation (reaching >0.8), given the nonsuperimposed sensor positions and similar power spectral density curves. Neurophysiologist reviews showed no statistically significant difference between dry and wet data on most clinically relevant EEG background and seizure patterns. There was no skin injury after 1 hour of dry sensor recordings. In contrast to wet electrodes, impedance and electrical artifact of dry sensors were largely unaffected by simulated vernix. CONCLUSIONS: Dry sensors evaluated in this study have the potential to provide high-quality, timely EEG recordings on neonates with less risk of skin injury.

Noncontact ECG system for unobtrusive long-term monitoring.

This paper describes measurements made using an ECG system with QUASAR's capacitive bioelectrodes integrated into a pad system that is placed over a chair. QUASAR's capacitive bioelectrode has the property of measuring bioelectric potentials at a small separation from the body. This enables the measurement of ECG signals through fabric, without the removal of clothing or preparation of skin. The ECG was measured through the subject's clothing while the subject sat in the chair without any supporting action from the subject. The ECG pad system is an example of a high compliance system that places minimal requirements upon the subject and, consequently, can be used to generate a long-term record from ECG segments collected on a daily basis, providing valuable information on long-term trends in cardiac health.

QUASAR's QStates cognitive gauge performance in the cognitive state assessment competition 2011.

The Cognitive State Assessment Competition 2011 was organized by the U.S. Air Force Research Laboratory (AFRL) to compare the performance of real-time cognitive state classification software. This paper presents results for QUASAR's data classification module, QStates, which is a software package for real-time (and off-line) analysis of physiologic data collected during cognitive-specific tasks. The classifier's methodology can be generalized to any particular cognitive state; QStates identifies the most salient features extracted from EEG signals recorded during different cognitive states or loads.

A wearable physiological sensor suite for unobtrusive monitoring of physiological and cognitive state.

This paper describes an integrated Physiological Sensor Suite (PSS) based upon QUASAR's innovative non-invasive bioelectric sensor technologies that will provide, for the first time, a fully integrated, noninvasive methodology for physiological sensing. The PSS currently under development at QUASAR is a state-of-the-art multimodal array of sensors that, along with an ultra-low power personal area wireless network, form a comprehensive body-worn system for real-time monitoring of subject physiology and cognitive status. Applications of the PSS extend from monitoring of military personnel to long-term monitoring of patients diagnosed with cardiac or neurological conditions. Results for side-by-side comparisons between QUASAR's biosensor technology and conventional wet electrodes are presented. The signal fidelity for bioelectric measurements using QUASAR's biosensors is comparable to that for wet electrodes.